Ryuta Takeda received Ph.D. from The Ohio State University, and trained as a pure scientist in a biotech field. After joining Leave a Nest, he initiated the ASEAN largest Deeptech entrepreneur platform "TECH PLANTER" in Japan, and managed to spread it to 10 countries to explore In USA, from 2016-2019, he held TECH PLANTER in Silicon Valley and Boston. businesses in Leave a Nest, he also developed a lot of international PoCs and collaborative researches between MNC and startup and different startups, so He also developed a lot of international PoCs and collaborative researches between MNC and startup and different startups, so called international co-creation activities.

Dr Sarkar did his PhD from University of Cambridge (2002-2006) followed by postdoctoral research at the University of Cambridge (2007 -2010) and Whitehead Institute for Biomedical Research at Massachusetts Institute of Technology (2010-2014), after which -2010) and Whitehead Institute for Biomedical Research at Massachusetts Institute of Technology (2010-2014), after which His seminal contributions in the field of autophagy include the identification of mTOR-independent His current research involves studying the homeostatic role, the homeostatic role, the homeostatic effect, the homeostatic effect, the homeostatic effect, the homeostatic effect, the homeostatic effect, the homeostatic effect, and the homeostatic effect. His current research involves studying the homeostatic role, dysfunction and therapeutic manipulation of autophagy in human physiology and disease by utilizing human His current research involves studying the homeostatic role, dysfunction and therapeutic manipulation of autophagy in human physiology and disease by utilizing human pluripotent stem cell based platforms.

After being diagnosed with multiple autoimmune diseases and being told she had 5 years left to live , she began research herself and used novel therapies to reverse her autoimmune condition. After being diagnosed with multiple autoimmune diseases and being told she had 5 years left to live , she began research herself and used novel therapies to reverse her autoimmune condition. She has been in remission for 19 years. She then began fundraising for Oxford University regenerative biotech spinout companies in stem cell, stem cell expansion She then began fundraising for Oxford University regenerative biotech spinout companies in stem cells, stem cell expansion, lysosomal storage disorders and ketones in 2018 and launched Oxford Healthspan in 2020. She promotes the idea of incorporating ways to activate autophagy into daily life as an autoimmune patient advocate and as Co-Founder of the non-profit, Oxford Longevity Project, which holds webinars and conferences for the public on how to incorporate breakthrough science, especially autophagy, into daily life.

While a master's student at the University of Tokyo's Graduate School of Agricultural and Life Sciences in 2005, he helped found Euglena Co. He is a team leader of the Microalgae Production Control Technology Research Team at RIKEN, a visiting professor at the He is a team leader of the Microalgae Production Control Technology Research Team at RIKEN, a visiting professor at the Malaysian-Japanese International Institute of Technology, Universiti Teknologi Malaysia, and a specially appointed (visiting) professor at Tohoku University's Graduate Program of Excellence. He is the author of "Dr. Green Beetle's Super He is the author of "Dr. Green Beetle's Super Entrepreneurial Thinking" (Nikkei BP).